Posts by che346
World class clinical trials
CSIRO's clinical trial capability spans nutrition research, health diagnostics and vaccines. With the latest technology, equipment and facilities, we lead scientific studies in collaboration with industry and governments. CSIRO’s researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.
CSIRO is involved in a broad range of activities with governments and industry in response to COVID-19, including preclinical testing of potential vaccines, understanding the virus and its mutations, monitoring wastewater, supporting manufacturing of surgical masks, and analysing and sharing trends in data and the impact on health services.
CSIRO helps Australia’s biomedical industry grow and compete globally. We work with individual researchers, start‑ups, SMEs, large companies and public research institutions on a broad range of projects. With world-class researchers and facilities, and people who understand our industry from both a technical and commercial perspective, CSIRO is your ultimate partner.
Digital transformation of healthcare
CSIRO has world leading capability in areas such as clinical terminology and data interoperability; health data and genomic analytics; applied bioinfomatics and engineering. We are enabling the digital transformation of healthcare to improve services and clinical treatment for Australia and the world.
Australian Centre for Disease Preparedness
CSIRO hosts the only high-containment facility in the southern hemisphere. The PC4 environment of the Australian Centre for Disease Preparedness (ACDP) supports a zoonosis suite and bioimaging facility and insectary with advanced technology and infrastructure. ACDP works closely with veterinary and human health agencies globally providing research and advice on exotic, emerging and re-emerging diseases related to biosecurity and counter-bioterrorism. The ACDP was involved in key research driving rapid global response to COVID-19.